Neurotech International

Neurotech International Equity

The The Equity of Neurotech International (NTI.AX) as of Oct 13, 2026 is 611,141.00 AUD. In the previous year, The Equity was 2.95 M AUD — a change of -79.32% (lower).

Equity

611,141.00AUD

YoY

-79.32%

Last updated:

In 2026, Neurotech International's equity was 611,141.00 AUD, a -79.32% increase from the 2.95 M AUD equity in the previous year.

The Neurotech International Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
297,413.00 AUD
Jan 1, 2020
-646,293.00 AUD
Jan 1, 2021
3.86 M AUD
Jan 1, 2022
1.43 M AUD
Jan 1, 2023
3.96 M AUD
Jan 1, 2024
11.90 M AUD
Jan 1, 2025
2.95 M AUD
Jan 1, 2026
611,141.00 AUD
The Neurotech International Equity history
YEAREquityYoY
611,141.00AUD-79.32%
2.95 MAUD-75.17%
11.90 MAUD+200.32%
3.96 MAUD+177.06%
1.43 MAUD-62.97%
3.86 MAUD-697.48%
-646,293.00AUD-317.30%
297,413.00AUD-92.97%
4.23 MAUD-1.49%
4.30 MAUD-43.00%
7.54 MAUD+482.02%
1.29 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Neurotech International Stock analysis

What does Neurotech International do? Neurotech International is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Neurotech International's Equity

Neurotech International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Neurotech International's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Neurotech International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Neurotech International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Neurotech International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Neurotech International stock

The Equity of Neurotech International is 611,141.00 AUD in 2026.

The Equity of Neurotech International changed from 2.95 M AUD to 611,141.00 AUD, representing a -79.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Neurotech International since 2006 – with annual values, charts, and detailed analysis.

The Equity's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Neurotech International historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Neurotech International

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Neurotech International